| Class 1 Device Recall ReSTOR IOL | |
Date Initiated by Firm | April 15, 2015 |
Date Posted | August 07, 2015 |
Recall Status1 |
Terminated 3 on June 30, 2017 |
Recall Number | Z-2323-2015 |
Recall Event ID |
71630 |
Product Classification |
intraocular lens - Product Code HQL
|
Product | ReSTOR intraocular lens and ReSTOR Toric intraocular lens.
The Alcon AcrySof IQ ReSTOR and IQ ReSTOR Toric intraocular lenses are posterior chamber lenses intended as optical implants designed to replace the human crystalline lens in adult patients following cataract surgery. The lenses subject to this correction are manufactured specifically for Japan. |
Code Information |
Model Numbers: SN6AD1, SN6AD3, SV25T0, MN6AD1,SND1T3, SND1T4, SND1T5 and SND1T6 and all lot numbers. |
Recalling Firm/ Manufacturer |
Alcon Research, Ltd. 6201 South Fwy Fort Worth TX 76134-2099
|
For Additional Information Contact | N/A 800-862-5266 |
Manufacturer Reason for Recall | There are reports of post - operative inflammation and/or toxic anterior segment syndrome (TASS) after cataract surgery. |
FDA Determined Cause 2 | Process design |
Action | Alcon Research sent recall notification letters dated April 16, 2015, to all affected consignees. The letter identified the product, the problem, and the action to be taken by the customer. Customers were instructed to stop using the affected product and place on hold until their sales representatives visit their site for withdrawal. Follow up communication activities included personal contact via phone and site visits. For questions regarding this recall call 817-293-0450. |
Quantity in Commerce | 45,391 |
Distribution | Distribution Japan, No US distribution. |
Total Product Life Cycle | TPLC Device Report |
|
1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls. 2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall. 3 For details about termination of a recall see Code of Federal Regulations (CFR) Title 21 §7.55.
|
|
|
|